SEB Asset Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
SEB Asset Management's RVMD Position: Q3 2026 in Review
SEB Asset Management increased its Revolution Medicines (RVMD) stake by 0.41% in Q3 2026, buying an estimated $73.1K and bringing the position to 90,679 shares worth $18.6M. The position accounts for 0.07% of the portfolio, ranked #228.
SEB Asset Management first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- SEB Asset Management held 90,679 shares of Revolution Medicines worth $18.6M as of Q3 2026.
- SEB Asset Management bought 369 Revolution Medicines shares in Q3 2026, an estimated $73.1K.
- Revolution Medicines made up 0.07% of SEB Asset Management's portfolio in Q3 2026, its #228 holding.
- SEB Asset Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
- 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.